Our Mission
We are on a mission to make finger-prick blood glucose testing obsolete for people living with diabetes.
More than 164 million people in the Asia Pacific region are living with diabetes – that’s 38 percent of people with diabetes globally.
Through innovative technology, our goal is to free people living with diabetes from painful and invasive blood monitoring devices, giving them a better quality of life.
GBS Inc. is a biosensor diagnostic technology company focused on commercializing the Saliva Glucose Biosensor the Asia Pacific Region, including Australia, Indonesia, Japan and New Zealand. GBS Inc.
GBS Inc. is a proud member of The iQ Group Global, a group of companies committed to creating the medicines of the future. What starts here changes the world.

News
The iQ Group Global Introduces the Saliva Glucose Biosensor
The world’s first non-invasive, saliva-based glucose test for diabetes management SYDNEY – February , 2019 – The iQ Group Global, a consortium of life science and financial services companies which […]
The Saliva Glucose Biosensor
Replacing finger-pricks for people living with diabetes
The Saliva Glucose Biosensor is the first pain-free, non-invasive replacement for finger-prick blood glucose testing.
Through the regulatory process, we intend to demonstrate that the Saliva Glucose Biosensor can be used as a point of care test indicated for the management of diabetes, as non-adjunctive to blood glucose testing for diabetes treatment decisions.

1

2

3
For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.